Concepts (53)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colonic Pouches | 1 | 2023 | 122 | 0.200 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2023 | 190 | 0.190 |
Why?
|
| Carcinoma, Small Cell | 1 | 2023 | 420 | 0.190 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 926 | 0.120 |
Why?
|
| Colitis, Ulcerative | 1 | 2023 | 1920 | 0.090 |
Why?
|
| Breast Neoplasms | 2 | 2023 | 20982 | 0.060 |
Why?
|
| Cervix Uteri | 1 | 2006 | 570 | 0.050 |
Why?
|
| Anal Canal | 1 | 2023 | 374 | 0.050 |
Why?
|
| Papillomaviridae | 1 | 2006 | 1120 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 2002 | 551 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2023 | 982 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2006 | 2195 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 665 | 0.040 |
Why?
|
| Serine Endopeptidases | 1 | 2004 | 1022 | 0.040 |
Why?
|
| Rectum | 1 | 2023 | 891 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2021 | 1150 | 0.040 |
Why?
|
| Haplotypes | 1 | 2004 | 2715 | 0.040 |
Why?
|
| Antigen Presentation | 1 | 2002 | 1251 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2002 | 1348 | 0.030 |
Why?
|
| Papillomavirus Infections | 1 | 2006 | 1616 | 0.030 |
Why?
|
| Mastectomy | 1 | 2023 | 1818 | 0.030 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2006 | 2019 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2023 | 3512 | 0.030 |
Why?
|
| Breast | 1 | 2021 | 1964 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2023 | 2827 | 0.020 |
Why?
|
| Mammography | 1 | 2021 | 2430 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2004 | 8479 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2023 | 9187 | 0.020 |
Why?
|
| Vaginal Smears | 1 | 2006 | 499 | 0.010 |
Why?
|
| Proprotein Convertases | 1 | 2004 | 95 | 0.010 |
Why?
|
| H-2 Antigens | 1 | 2002 | 358 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 11733 | 0.010 |
Why?
|
| Diastole | 1 | 2004 | 782 | 0.010 |
Why?
|
| Sulfones | 1 | 2002 | 448 | 0.010 |
Why?
|
| Cytosol | 1 | 2002 | 883 | 0.010 |
Why?
|
| Ubiquitin | 1 | 2002 | 839 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2002 | 1179 | 0.010 |
Why?
|
| Female | 4 | 2023 | 392552 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2023 | 64681 | 0.010 |
Why?
|
| Humans | 5 | 2023 | 761222 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2002 | 1318 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2002 | 1783 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 80675 | 0.010 |
Why?
|
| Mass Screening | 1 | 2006 | 5426 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 18384 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2004 | 22174 | 0.000 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2004 | 15920 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2002 | 22128 | 0.000 |
Why?
|
| Adult | 2 | 2006 | 221120 | 0.000 |
Why?
|
| Mice | 1 | 2002 | 81330 | 0.000 |
Why?
|
| Middle Aged | 1 | 2006 | 220858 | 0.000 |
Why?
|
| Animals | 1 | 2002 | 168089 | 0.000 |
Why?
|
| Male | 1 | 2004 | 360703 | 0.000 |
Why?
|
Concepts
(53)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_